How Marie-Angélique Sène is empowering Africa’s vaccine future

Under the bright lights of a lab at Institut Pasteur de Dakar (IPD) in Senegal, anticipation filled the air. Marie-Angélique Sène’s team was preparing to share a groundbreaking innovation—the groundwork for the first-ever mRNA vaccine developed in Senegal—with a group of global health leaders. The vaccine, which targets Rift Valley fever—a virus which can cause severe disease in both people and animals—represents a milestone in global health innovation by advancing vaccine design and manufacturing, laying the foundation for future breakthroughs.As the Head of Advanced Vaccine Bioprocessing at IPD, Sène is leading all the work, from antigen design to manufacturing process development. Rather than take center stage herself, however, Sène let her team explain their trailblazing research to the visitors, including Bill Gates, as she beamed with pride. She had built this team of highly skilled scientists united by a mission to improve access to life-saving vaccines in Senegal and across Africa.

The road to this moment was anything but easy. Sène faced obstacles that could have ended her journey—but instead, they fueled her drive to lead her team to this major achievement.

Finding strength in the face of doubt

 

 

 

Breaking barriers in scientific leadership

At the start of her career, Sène often found her voice and expertise sidelined in male-dominated spaces. Determined to change this dynamic, she has worked to create leadership opportunities for others, especially women. As the head of Vaccine Research Center at IPD, Sène oversees a multigenerational team of scientists, most of them women.

Sène has learned that nurturing her team isn’t just about guiding their scientific work—it’s about helping shy, uncertain individuals blossom into leaders. “They come to me and say, ‘I didn’t know I could do this,’” she says. Now they are part of a team shaping the future of vaccine accessibility, developing manufacturing processes that could dramatically reduce disease rates across Africa and strengthen global health systems.

Empowering Africa’s next generation of innovators

Returning to Dakar as a leader at the Institut Pasteur de Dakar (IPD) felt like coming full circle for Sène—having attended her mother’s kindergarten just a short distance from the institute. For her, the journey home represents not only personal fulfillment but also a chance to empower the next generation of African scientists.

The mRNA vaccine her team is developing for Rift Valley fever has the potential to save countless lives across Africa, not only protecting people from severe disease but also safeguarding livestock that are essential to rural economies. By spearheading domestic vaccine production, Sène is helping Senegal reduce its reliance on external suppliers and positioning Africa as a leader in global health innovation. “The brains are here,” she says. “They just need the right tools and to be exposed to the right environment to thrive.”

 

About

The Daksha Foundation was created from a place of profound loss but with an unwavering commitment to hope, resilience, and change. Inspired by Daksha’s life and the struggles she endured, our foundation stands as a beacon for women facing emotional distress, betrayal, and hardship.

Share